CIPROFLOXACIN HCL
OPHTHALMIC ANTIBACTERIALS · TYPHOID FEVER ·+68
PROFICIENT RX L
Drug class
Quinolones
Quinolones are a class of synthetic broad-spectrum antibacterial agents that include classic agents like nalidixic acid and modern fluorinated derivatives known as fluoroquinolones. Read more about Quinolones
93 drugs in this class 54 manufacturers
Drugs in Quinolones
LEVOFLOXACIN
QUINOLONES · PLAGUE ·+53
PROFICIENT RX L
CIPROFLOXACIN HCL
QUINOLONES · TYPHOID FEVER ·+68
BRYANT RANCH PR
LEVOFLOXACIN
QUINOLONES · PLAGUE ·+53
BRYANT RANCH PR
CIPROFLOXACIN HCL
OPHTHALMIC ANTIBACTERIALS · TYPHOID FEVER ·+68
NUCARE PHARMACE
LEVOFLOXACIN
QUINOLONES · PLAGUE ·+53
NUCARE PHARMACE
CIPROFLOXACIN HCL
QUINOLONES · TYPHOID FEVER ·+68
WESTMINSTER PHA
CIPROFLOXACIN HCL
QUINOLONES · TYPHOID FEVER ·+68
DENTON PHARMA I
LEVOFLOXACIN
QUINOLONES · PLAGUE ·+53
DENTON PHARMA I
Filter & compare in the drug finder →
Opens the drug finder with Quinolones preselected. Add indication or manufacturer filters there.
Quinolones are a class of synthetic broad-spectrum antibacterial agents that include classic agents like nalidixic acid and modern fluorinated derivatives known as fluoroquinolones.
They exert bactericidal activity by inhibiting essential bacterial type II topoisomerases—specifically DNA gyrase and topoisomerase IV—which disrupts DNA replication, transcription, and repair, ultimately leading to bacterial chromosome fragmentation and cell death.
Clinically, members of this class are utilized to treat various moderate to severe bacterial infections, including complicated urinary tract infections, pyelonephritis, respiratory tract infections such as community-acquired pneumonia, gastrointestinal infections, and intra-abdominal or skin infections.
Because of notable safety concerns, including musculoskeletal and neurological toxicities, systemic use is often reserved for circumstances where alternative antimicrobial options are ineffective or inappropriate.
-
fda.gov
Quinolones are a class of synthetic broad-spectrum antibacterial agents that include classic agents like nalidixic acid and modern fluorinated derivatives known as fluoroquinolones
-
nih.gov
Quinolones are a class of synthetic broad-spectrum antibacterial agents that include classic agents like nalidixic acid and modern fluorinated derivatives known as fluoroquinolones They exert bactericidal activity by inhibiting essential bacterial type II topoisomerases—specifically DNA gyrase and topoisomerase IV—which disrupts DNA replication, transcription, and repair, ultimately leading to bacterial chromosome fragmentation and cell death
-
nih.gov
They exert bactericidal activity by inhibiting essential bacterial type II topoisomerases—specifically DNA gyrase and topoisomerase IV—which disrupts DNA replication, transcription, and repair, ultimately leading to bacterial chromosome fragmentation and cell death
-
nih.gov
Clinically, members of this class are utilized to treat various moderate to severe bacterial infections, including complicated urinary tract infections, pyelonephritis, respiratory tract infections such as community-acquired pneumonia, gastrointestinal infections, and intra-abdominal or skin infections
-
nih.gov
Clinically, members of this class are utilized to treat various moderate to severe bacterial infections, including complicated urinary tract infections, pyelonephritis, respiratory tract infections such as community-acquired pneumonia, gastrointestinal infections, and intra-abdominal or skin infections
-
nih.gov
Clinically, members of this class are utilized to treat various moderate to severe bacterial infections, including complicated urinary tract infections, pyelonephritis, respiratory tract infections such as community-acquired pneumonia, gastrointestinal infections, and intra-abdominal or skin infections
-
fda.gov
Because of notable safety concerns, including musculoskeletal and neurological toxicities, systemic use is often reserved for circumstances where alternative antimicrobial options are ineffective or inappropriate
-
nih.gov
Because of notable safety concerns, including musculoskeletal and neurological toxicities, systemic use is often reserved for circumstances where alternative antimicrobial options are ineffective or inappropriate
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.